NCT01122368View on ClinicalTrials.gov

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

July 13, 2010

Primary Completion Date

December 15, 2011

Study Completion Date

December 15, 2011

Conditions
Mycoses
Interventions
DRUG

micafungin

IV

DRUG

placebo

IV

Trial Locations (56)

1011

Lausanne

1030

Vienna

1070

Brussels

1090

Vienna

1200

Brussels

2650

Edegem

4000

Liège

4032

Debrecen

5020

Salzburg

6020

Innsbruck

6720

Szeged

8800

Viborg

9000

Ghent

9023

Győr

12461

Athens

20052

Monza

20142

Milan

23562

Lübeck

26480

Eskişehir

28006

Madrid

28046

Madrid

30625

Hanover

33521

Tampere

35100

Ege

37126

Verona

40138

Bologna

40620

Jyväskylä

46014

Valencia

47012

Valladolid

50098

Bucharest

50937

Cologne

52621

Ramat Gan

56126

Pisa

57001

Thessaloniki

57010

Thessaloniki

61080

Trabzon

64239

Tel Aviv

69495

Pierre-Bénite

70210

Kuopio

75674

Paris

75679

Paris

79106

Freiburg im Breisgau

84054

Amiens

85925

La Roche-sur-Yon

86021

Poitiers

87042

Limoges

300748

Timișoara

410168

Oradea

04103

Leipzig

00161

Roma

00168

Roma

08003

Barcelona

06100

Ankara

FY3 8NR

Blackpool

LS1 3EX

Leeds

LS9 7TF

Leeds

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY